Want to see GB:KMK full AI Analyst Report?
Top Page
Kromek Group plc
(LSE:KMK)
Select Model
Select Model
Rating:50Neutral
Price Target:
5.50 p
▼(-31.25% Downside)
Action:Downgraded
Date:09/15/26
The score is held back primarily by weakened 2026 financial momentum (revenue decline, margin compression, and sharply lower free cash flow) despite the broader profitability turnaround and solid balance sheet. Technicals reinforce the caution with a clear downtrend and negative MACD, while valuation is a further headwind due to a high P/E and no dividend yield provided.
Positive Factors
Return to profitability
The return to positive net income after heavy losses in 2021–2024 shows that the business has regained an earnings base. Although profitability weakened recently, continued annual profit provides greater capacity to fund operations, support customers, and pursue growth than during the prior loss-making period.
Negative Factors
Sharp revenue decline
A 28.3% annual revenue contraction indicates that recent demand or contract timing has not supported sustained top-line expansion. Lower sales can weaken operating leverage, reduce resources available for development, and make the profitability recovery more dependent on an uncertain return to growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Return to profitability
The return to positive net income after heavy losses in 2021–2024 shows that the business has regained an earnings base. Although profitability weakened recently, continued annual profit provides greater capacity to fund operations, support customers, and pursue growth than during the prior loss-making period.
Read all positive factors
Kromek Group plc (KMK) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£37.61M
Dividend YieldN/A
Average Volume (3M)1.67M
Price to Earnings (P/E)52.2
Beta (1Y)1.08
Revenue Growth2.30%
EPS Growth-81.36%
CountryUK
Employees166
SectorTechnology
Sector Strength88
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)<0.01
Shares Outstanding655,299,900
10 Day Avg. Volume1,292,577
30 Day Avg. Volume1,672,580
Financial Highlights & Ratios
PEG Ratio-1.17
Price to Book (P/B)1.26
Price to Sales (P/S)2.53
P/FCF Ratio25.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)£30.30M
Kromek Group plc Business Overview & Revenue Model
Company Description
Kromek Group plc, a UK-based entity established in 2013 with headquarters in Sedgefield, specializes in the design, production, and global distribution of advanced radiation detection components and devices. These technologies provide high-resolut...
How the Company Makes Money
Kromek makes money primarily by selling radiation detection products and related technology to commercial and government customers. Key revenue streams include: (1) Product sales of radiation detector components and systems: Kromek supplies detect...
Kromek Group plc Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
71
Positive
Cash Flow
49
Neutral
| Breakdown | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 27.11M | 26.51M | 19.40M | 17.31M | 12.05M |
| Gross Profit | 14.00M | 21.43M | 10.71M | 6.04M | 3.07M |
| EBITDA | 7.00M | 9.30M | 2.93M | -1.25M | -1.23M |
| Net Income | 733.00K | 3.75M | -3.29M | -6.10M | -4.92M |
Balance Sheet | |||||
| Total Assets | 70.27M | 65.87M | 70.19M | 63.88M | 67.42M |
| Cash, Cash Equivalents and Short-Term Investments | 4.16M | 1.70M | 466.00K | 1.10M | 5.08M |
| Total Debt | 9.36M | 4.05M | 12.29M | 13.38M | 11.00M |
| Total Liabilities | 15.84M | 13.69M | 20.84M | 22.35M | 19.99M |
| Stockholders Equity | 54.43M | 52.18M | 49.35M | 41.52M | 47.44M |
Cash Flow | |||||
| Free Cash Flow | 2.67M | 15.71M | -7.84M | -5.78M | -10.29M |
| Operating Cash Flow | 3.00M | 15.90M | -2.80M | -504.00K | -3.84M |
| Investing Cash Flow | -4.94M | -4.55M | -5.00M | -5.27M | -6.45M |
| Financing Cash Flow | 4.56M | -9.19M | 7.18M | 1.99M | -1.23M |
Kromek Group plc Technical Analysis
Negative
8.00
Price Trends
7.33
Negative
7.90
Negative
9.24
Negative
Market Momentum
-0.41
Positive
30.43
Neutral
16.21
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:KMK, the sentiment is Negative. The current price of 8 is above the 20-day moving average (MA) of 6.31, above the 50-day MA of 7.33, and below the 200-day MA of 9.24, indicating a bearish trend. The MACD of -0.41 indicates Positive momentum. The RSI at 30.43 is Neutral, neither overbought nor oversold. The STOCH value of 16.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:KMK.
Kromek Group plc Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | £335.29M | 83.05 | 3.33% | 0.80% | 12.73% | -26.74% | |
64 Neutral | £840.10M | 29.13 | 9.04% | 1.49% | 4.82% | 17.80% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | £323.01M | -9.04 | -24.38% | 3.68% | -2.68% | 47.33% | |
54 Neutral | £239.79M | -400.00 | -0.72% | 3.29% | -8.18% | -105.44% | |
50 Neutral | £37.61M | 52.18 | 1.32% | ― | 2.30% | -81.36% | |
39 Underperform | £8.52M | -1.17 | -68.21% | ― | -29.53% | -210.26% |
* Technology Sector Average
GB:KMK
Kromek Group plc
5.74
-0.76
-11.69%
GB:GHH
Gooch & Housego
1,225.00
646.78
111.86%
GB:JDG
Judges Scientific
3,600.00
-2,230.88
-38.26%
GB:TTG
TT Electronics
181.00
78.80
77.10%
GB:WPHO
Windar Photonics
4.13
-49.88
-92.36%
GB:DSCV
discoverIE Group plc
874.00
298.52
51.87%
Kromek Group plc Corporate Events
Business Operations and StrategyExecutive/Board ChangesPrivate Placements and FinancingShareholder Meetings
Kromek bolsters board and expands HSBC credit line ahead of AGM
Positive
Oct 2, 2026
Kromek Group plc has called its Annual General Meeting for 23 October 2026 at its NETPark headquarters and has released its annual report and accounts for the year ended 30 April 2026 to shareholders and via its investor relations website. The com...
Business Operations and StrategyFinancial Disclosures
Kromek to Host Investor Q&A Following Release of 2026 Final Results
Positive
Sep 16, 2026
Kromek Group plc has invited investors to an online QA webinar with CEO Arnab Basu and CFO Claire Burgess on 21 September 2026, following the publication of its final results for the year ended 30 April 2026. A pre-recorded results presentation wi...
Business Operations and Strategy
Kromek Chairman Increases Stake with Share Purchase
Positive
Sep 15, 2026
Kromek Group plc has disclosed that its non-executive chairman, Rakesh Sharma, purchased 145,454 ordinary shares at 6.88p each on 15 September 2026. Following this transaction, Sharma and his wife now hold 1,729,167 shares, representing around 0.3...
Other
Kromek Chairman’s Family Boosts Stake With Share Purchase
Positive
Sep 14, 2026
Kromek Group plc reported that Kathleen Sharma, wife of Non-executive Chairman Rakesh Sharma, acquired 144,092 ordinary shares at 6.94 pence apiece on 14 September 2026. Following the transaction, Mr. Sharma’s total interest, including his w...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
Kromek boosts underlying imaging growth and secures key security contracts in FY 2026
Positive
Sep 14, 2026
Kromek Group plc, a specialist in advanced imaging and CBRN detection technologies, reported modest revenue growth to £27.1m for the year to 30 April 2026, driven by a strong underlying performance in Advanced Imaging and rising demand in CBR...
Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures
Kromek hits third Siemens milestone and awards executives new share options
Positive
Aug 6, 2026
Kromek Group plc, a global detection specialist listed on AIM, develops radiation and bio-detection solutions for advanced medical imaging, security and industrial applications, as well as CBRN detection systems for defence and homeland security m...
Other
Kromek Chairman Rakesh Sharma Increases Stake with Share Purchase
Positive
Aug 3, 2026
Kromek Group plc has disclosed that its non‑executive chairman, Rakesh Sharma, purchased 129,413 ordinary shares at 7.57p per share on 31 July, increasing his holding to 1,439,621 shares, or about 0.2% of the company’s issued share cap...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.